Ultomiris Solution, Concentrate
Product Images NDC 25682-028

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ultomiris (NDC 25682-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alexion Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (30 mL Vial Carton)

A two-panel line graph comparing the change from baseline in MG-ADL total score (panel A) and QMG total score (panel B) over 26 weeks between Ultomiris and placebo groups. Ultomiris is represented by a solid blue line with square markers, and placebo by a dotted red line with circular markers. Both panels show greater score reductions (improvement) over time in the Ultomiris group compared to placebo, with error bars depicting variability at each time point.*

FDA Label Image

Ultomiris 02

Carton label for Ultomiris (ravulizumab-cwvz) injection, 300 mg/30 mL (10 mg/mL) solution concentrate for intravenous infusion. The label includes dosing instructions, storage conditions (refrigerate 2°C–8°C, protect from light, do not freeze or shake), and filtration requirements. Manufactured by Alexion Pharmaceuticals Inc., Boston, MA. The carton features barcodes and NDC 25682-022-01.*

FDA Label Image

Ultomiris 03

Ultomiris (ravulizumab-cwvz) injection 300 mg/3 mL (100 mg/mL) solution concentrate for intravenous infusion. The carton label highlights dilution instructions with 0.9% Sodium Chloride and specifies a 3 mL single-dose vial with unused portion discard instructions. Manufactured by Alexion Pharmaceuticals Inc., the label includes storage details and filter administration guidance.*

FDA Label Image

Ultomiris 04

Packaging label for Ultomiris (ravulizumab-cwvz) Injection 1,100 mg/11 mL (100 mg/mL) solution concentrate for intravenous infusion. The label includes dosage form and strength, storage instructions (refrigerate, protect from light, do not freeze or shake), administration guidelines, and manufacturer information for Alexion Pharmaceuticals Inc. The label also features the NDC 25682-028-01 and highlights a new concentration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.